PROVIDER PROFILE · NPI 1730114620

Alan RothbergerM.D.

Internal MedicineBrooklyn, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,838

Unique beneficiaries

—

Total services

2,213

Distinct HCPCS

Medicare payment

$120K

Peer benchmark

Total Medicare services vs. 7,864 Internal Medicine providers in NY — top quintile (cohort median 552).

PRESCRIBING · PART D · 2024

Total Rx claims

5,074

Beneficiaries

—

Total drug cost

$247K

Distinct drugs

Brand share

14.1%

Top prescribed drugs

Atorvastatin Calcium467 claims

Losartan Potassium375 claims

Amlodipine Besylate300 claims

Metformin Hcl222 claims

Pantoprazole Sodium217 claims

QUALITY · MIPS · 2024

Final MIPS score

55.5

Quality

80.0

Cost

78.4

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

-2.34%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Alan Rothberger's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
MAIMONIDES MEDICAL CENTER	51	161
Melvin Rothberger Ophthalmology · Brooklyn, NY	38	81
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	20	36
BETH ISRAEL MEDICAL CENTER	16	39
Ben Jacobs Urology · Brooklyn, NY	13	22
Quality Healthcare Management Inc Clinical Laboratory · Brooklyn, NY	13	71

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history